PMcardio receives FDA Breakthrough Device Designation — read the full story
Powerful Medical
27. June 2024
3 min to read

Application of the Artificial Intelligence Model for Detection of Electrocardiographic Signs of Coronary Occlusion in Patients with Non ST-Elevation Acute Coronary Syndrome

Overview:

Many heart attacks do not fit the textbook definition and occur without classic ST-elevation seen on ECG, complicating diagnosis. This single-center retrospective evaluation at the National Amosov Institute of Cardiovascular Surgery assessed the PMcardio STEMI AI ECG Model’s ability to detect these subtle cases. The model achieved 85.3% accuracy, 67% sensitivity, and 93% specificity, highlighting its potential to help clinicians identify high-risk patients earlier, enabling timely and targeted care.

Published In: Ukrainian Journal of Cardiovascular Surgery 
Presented Date: June 27, 2024

Aim

This study aimed to determine the effectiveness of the OMI AI deep learning model for the diagnosis of myocardial infarction in patients with non ST-elevation acute coronary syndrome.

Methods

This single-center retrospective observational study analyzed the data of 238 patients admitted to the National Amosov Institute of Cardiovascular Surgery of the National Academy of Medical Sciences of Ukraine with a primary diagnosis of non ST-elevation acute coronary syndrome.

The inclusion criteria for the study were: age ≥18 years, symptoms of acute coronary syndrome, at least one 10-second 12-lead electrocardiography on admission, no changes typical of ST-segment elevation myocardial infarction on electrocardiography, and at least one laboratory blood test for biomarkers of myocardial damage.

Results

The final analysis included data from 116 patients, 69 (59.5%) men and 47 (40.5%) women aged 43 to 88 years (mean age 67±11 years), of whom 34 were older patients (≥75 years). Of these, 29 (25%) patients were discharged with a diagnosis of acute myocardial infarction, 60 (51.7%) with a diagnosis of unstable angina, and 27 (23.3%) patients with other diagnoses.

When analyzing electrocardiographic data by the OMI AI model, true positive results were obtained in 23 cases (19.8%), true negative results in 76 cases (65.5%), false positive results in 11 cases (9.5%), and false negative results in 6 cases (5%).

Accordingly, the model’s sensitivity was 67% and specificity was 93%. The positive and negative predictive values for the model under study were 0.793 and 0.874, respectively. The accuracy of the model was 85.34% (95% CI: 77.78% to 90.64%).

Conclusion

The use of the artificial intelligence tools has the potential to improve the accuracy of diagnosis of myocardial infarction during hospitalization, accelerate the provision of specialized care and improve prognosis in patients with non ST-elevation acute coronary syndrome.


Authors: Sviatoslav A. Kalashnikov, Sergii V. Salo, Andrii V. Stepaniuk, Sabi Sandu, Vasyl V. Lazoryshynets

Author-Logo_PM
Powerful Medical leads one of the most important shifts in modern medicine by augmenting human-made clinical decisions with artificial intelligence. Our primary focus is on cardiovascular diseases, the world’s leading cause of death.

About PMcardio

PMcardio is the market leader in AI-powered diagnostics, addressing the world’s leading cause of death – cardiovascular diseases. The innovative clinical assistant empowers healthcare professionals to detect up to 40 cardiovascular diseases. In the form of a smartphone application, the certified Class IIb medical device interprets any 12-lead ECG image in under 5 seconds to provide accurate diagnoses and individualized treatment recommendations tailored to each patient.

About Powerful Medical

Established in 2017, Powerful Medical has embarked on a mission to revolutionize the diagnosis and treatment of cardiovascular diseases. We are a medical company backed by 28 world-class cardiologists and led by our expert Scientific Board with decades of experience in daily patient care, clinical research, and medical devices. The results of our research are implemented, developed, certified, and brought to market by our 50+ strong interdisciplinary team of physicians, data scientists, AI experts, software engineers, regulatory specialists, and commercial teams.

Share this article

Relevant Publications

Precordial Swirl Sign: A New ECG Pattern of Left Anterior Descending Artery Occlusion Myocardial Infarction

This study identifies the novel “precordial swirl sign,” a distinct ECG pattern that can uncover critical LAD coronary artery blockages often missed by standard STEMI criteria. It offers a promising step toward earlier and more accurate detection of high-risk heart attacks.

First Objective Definition of Hyperacute T-waves as a ST-segment Elevation Myocardial Infarction Equivalent ECG Finding

This abstract introduces the first objective definition of hyperacute T-waves — an early and often missed ECG sign of a severe heart attack. By accurately detecting blocked arteries even before classic signs appear, the new formula helps doctors identify high-risk patients sooner and deliver life-saving treatment faster.

Join over 100,000 healthcare professionals who are already taking advantage of AI